Compound 18a5
Product Specifications
Bioactivity
Compound 18a5 was demonstrated to be a promising lead compound for the treatment of TNBC by degrading ANXA3.
Smiles
O=C(CSC(NC1C(N(C(C)C)C(C=CC=C2)=C2C(C3=CC=CC=C3)=N1)=O)=S)N(CC4)CCN4C5=NC=CC=C5
Molecular Formula
C30H32N6O2S2
Molecular Weight
572.74
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/305058652820078608/T204004
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
BNUB1878-500 1x 500 µL
Bcl-2 (Apoptosis & Follicular Lymphoma Marker) (BCL2/1878R), 0.2mg/mL
Ask
View Details